Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Angiogenesis is the process by which tumours induce a blood supply, crucial for growth and metastasis. Evidence for its role in bladder carcinogenesis, its usefulness as a marker of patient prognosis, and potential anti-angiogenic therapies for future development are discussed in this chapter.

Original publication

DOI

10.1016/s0960-7404(02)00013-0

Type

Journal article

Journal

Surg Oncol

Publication Date

06/2002

Volume

11

Pages

85 - 100

Keywords

Angiogenesis Inducing Agents, Angiogenesis Inhibitors, Animals, Cyclohexanes, DNA-Binding Proteins, Drug Combinations, Endothelial Growth Factors, Humans, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit, Lymphokines, Mice, Mice, Nude, Neovascularization, Pathologic, Nuclear Proteins, O-(Chloroacetylcarbamoyl)fumagillol, Piperidines, Quinazolines, Quinazolinones, Sesquiterpenes, Thymidine Phosphorylase, Transcription Factors, Urinary Bladder Neoplasms, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors